Académique Documents
Professionnel Documents
Culture Documents
Contraception, 673697
barrier methods of, 687691
for breast-feeding women, 652, 652t
chronic hypertension and, 993
counseling on, postpartum, 657
for diabetic patient, 1112, 1121
emergency, 10
for sexual assault victim, 937
for epileptic patients, 1167
failed
body mass index (BMI) and, 951
and ectopic pregnancy, 238239
failure of, during first year of use, 675t
heart disease and, 962963
for HIV-infected (AIDS) patients, 1253
hormonal, 673682
implant, for breast-feeding women, 652t
injectable
medroxyprogesterone acetate, 682683
norethisterone enanthate, 682683
progestin, 682683
intramuscular administration of, 682
and lactation, 680, 694
methods, 674, 675t
mechanical, 684694
nonuse, prepregnancy prevalence of, 175t
obesity and, 951
periodic (rhythmic) abstinence methods,
675t, 692
postpartum, 657
progestational, 682683
progestin implants, 683
prosthetic heart valves and, 964
rheumatoid arthritis and, 1157
safety of, 674
in sickle-cell hemoglobinopathy, 1089
sickle-cell trait and, 1089
spermicidal, 688690, 690f
and spontaneous abortion, 218
systemic lupus erythematosus and, 1151
systemic sclerosis and, 1158
transdermal administration of, 681, 681f
use of
and determination of gestational age,
195
in U.S., 674, 674f, 675f, 675t
World Health Organization (WHO)
guides for, 674
Contraceptive patch (EVRA), failure of,
during first year of use, 675t
Contraceptive patch (Ortho Evra), 681, 681f
failure of, risk factors for, 681
Contraceptive sponge, 691, 691f
failure of, during first year of use, 675t
Williams Obstetric